Skip to main content
Clinical Trials/NL-OMON23630
NL-OMON23630
Completed
Not Applicable

on-invasive measurement of mitochondrial function in vivo in septic patients (a pilot study)

ot applicable0 sites45 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
ot applicable
Enrollment
45
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Intensive care patients:
  • In order to be eligible to participate in this study, a subject must meet the following criteria:
  • 18\-90 years of age
  • Admission to intensive care ward within 72 hours before inclusion.
  • Aged and gender matched healthy controls:
  • 18\-90 years of age
  • No relevant comorbidities (ASA I/II)
  • Matched in age (±5 years) and gender to one of the participants in the COVID 19 group.

Exclusion Criteria

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • Mentally disabled
  • Presence of mitochondrial disease
  • Healthy controls group:
  • Presence of COVID\-19//sepsis related complains or symptoms
  • Presence of COVID\-19/sepsis symptoms or complains, or a positive COVID\-19 test less than one month ago
  • COVID\-19 vaccination less than two weeks ago

Outcomes

Primary Outcomes

Not specified

Similar Trials